19.30

0.05% -0.010

Core Laboratories Inc (CLB)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Core Laboratories Inc stock is traded at $19.30, with a volume of 67,467. It is down -0.05% in the last 24 hours and down -2.62% over the past month. Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Previous Close:

$19.31

Open:

$19.45

24h Volume:

67,467

Relative Volume:

0.19

Market Cap:

$916.94M

Revenue:

$502.79M

Net Income/Loss:

$23.71M

P/E Ratio:

38.60

EPS:

0.5

Net Cash Flow:

$6.35M

1W Performance:

-1.03%

1M Performance:

-2.62%

6M Performance:

+21.23%

1Y Performance:

-8.62%

1-Day Range:

$19.23

$19.67

1-Week Range:

$18.75

$19.67

52-Week Range:

$13.82

$25.13

Core Laboratories Inc Stock (CLB) Company Profile

Name

Core Laboratories Inc

Sector

Energy (249)

Industry

Oil & Gas Equipment & Services (49)

Phone

713-328-2673

Address

6316 WINDFERN ROAD, HOUSTON

Employee

3,600

Twitter

@corelabcompany

Next Earnings Date

2024-10-23

Latest SEC Filings

CLB's Discussions on Twitter

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-23	Downgrade	Citigroup	Neutral → Sell
Apr-18-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-09-23	Upgrade	BofA Securities	Underperform → Neutral
Oct-07-22	Upgrade	Citigroup	Sell → Neutral
Sep-26-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Apr-18-22	Downgrade	Piper Sandler	Neutral → Underweight
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform
Jul-09-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-14-21	Downgrade	Citigroup	Neutral → Sell
Dec-18-20	Downgrade	JP Morgan	Neutral → Underweight
Nov-11-20	Reiterated	Cowen	Market Perform
Oct-13-20	Upgrade	BofA Securities	Underperform → Neutral
Sep-29-20	Upgrade	ABN Amro	Sell → Hold
Jul-16-20	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Apr-13-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Mar-09-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-09-20	Downgrade	Evercore ISI	Outperform → In-line
Jan-31-20	Reiterated	Cowen	Market Perform
Jan-30-20	Resumed	Johnson Rice	Buy
Jan-14-20	Initiated	Bernstein	Mkt Perform
Jan-02-20	Downgrade	Stifel	Buy → Hold
Dec-31-19	Reiterated	Cowen	Market Perform
Jul-10-19	Upgrade	BofA/Merrill	Neutral → Buy
Feb-25-19	Upgrade	Tudor Pickering	Hold → Buy
Dec-19-18	Downgrade	Credit Suisse	Outperform → Neutral
Dec-11-18	Downgrade	JP Morgan	Overweight → Neutral
Nov-16-18	Upgrade	Guggenheim	Neutral → Buy
Nov-01-18	Upgrade	ABN Amro	Sell → Buy
Oct-29-18	Reiterated	Cowen	Market Perform

View All

Core Laboratories Inc Stock (CLB) Latest News

Nov 04, 2024

Citigroup Issues Pessimistic Forecast for Core Laboratories (NYSE:CLB) Stock Price - Defense World

Nov 04, 2024

Nov 03, 2024

Core Laboratories Inc. (NYSE:CLB) Receives $18.00 Average Target Price from Analysts - Defense World

Nov 03, 2024

Nov 02, 2024

Core Laboratories Inc. (NYSE:CLB) Holdings Cut by Creative Planning - Defense World

Nov 02, 2024

Oct 30, 2024

Core Laboratories Inc. (NYSE:CLB) Stake Reduced by Boston Trust Walden Corp - MarketBeat

Oct 27, 2024

Oct 25, 2024

Core Laboratories N.V. (NYSE:CLB) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 25, 2024

Core Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Oct 25, 2024

Core Laboratories' Q3 Earnings and Sales Beat Estimates - MSN

Oct 25, 2024